Bio-Works Technologies AB (1BD) Financial Statements
Bio-Works Technologies AB Financial Overview
Bio-Works Technologies AB's market cap is currently $27.51M. The company's EPS TTM is ―; its P/E ratio is 133.16; Bio-Works Technologies AB has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ― | ― | ― | ― | ― |
| Gross Profit | $ 18.56M | $ 4.22M | $ 5.37M | $ 6.14M | $ 5.21M |
| Operating Income | $ -10.96M | $ -45.65M | $ -42.13M | $ -38.14M | $ -23.58M |
| EBITDA | $ -8.60M | $ -44.31M | $ -40.30M | $ -31.02M | $ -21.37M |
| Net Income | $ -12.94M | $ -45.02M | $ -42.11M | $ -37.95M | $ -23.66M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ― | ― | ― | ― | ― |
| Total Assets | $ 120.86M | $ 45.50M | $ 88.02M | $ 67.41M | $ 105.31M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -102.75M | $ -33.06M | $ -76.40M | $ -54.06M | $ -89.25M |
| Total Liabilities | $ 12.35M | $ 8.04M | $ 5.89M | $ 5.76M | $ 5.99M |
| Stockholders' Equity | ― | ― | ― | ― | ― |
| Cash Flow | |||||
| Free Cash Flow | $ -14.31M | $ -43.69M | $ -40.26M | $ -35.47M | $ -23.22M |
| Operating Cash Flow | ― | ― | ― | ― | ― |
| Investing Cash Flow | ― | ― | ― | ― | ― |
| Financing Cash Flow | ― | ― | ― | ― | ― |
Currency in USD